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Capsaicin, a transient receptor potential vanilloid type 1 (TRPV1) ligand, regulates nerve-related pain-sensitive signals, inﬂam-
mation, and cancer growth. Capsaicin suppresses interleukin-1-induced osteoclast diﬀerentiation, but its roles in bone tissues and
bone diseases are not known. This study examined the eﬀects of capsaicin on inﬂammatory bone resorption and prostaglandin
E (PGE) production induced by lipopolysaccharide (LPS) in vitro and on bone mass in LPS-treated mice in vivo. Capsaicin sup-
pressed osteoclast formation, bone resorption, and PGE production induced by LPS in vitro. Capsaicin suppressed the expression
of cyclooxygenase-2 (COX-2) and membrane-bound PGE synthase-1 (mPGES-1) mRNAs and PGE production induced by LPS in
osteoblasts. Capsaicin may suppress PGE production by inhibiting the expression of COX-2 and mPGES-1 in osteoblasts and LPS-
induced bone resorption by TRPV1 signals because osteoblasts express TRPV1. LPS treatment markedly induced bone loss in the
femur in mice, and capsaicin signiﬁcantly restored the inﬂammatory bone loss induced by LPS in mice. TRPV1 ligands like cap-
saicin may therefore be potentially useful as clinical drugs targeting bone diseases associated with inﬂammatory bone resorption.
1.Introduction
Bone remodeling is regulated by osteoclastic bone resorption
and new bone formation by osteoblasts. Prostaglandin E2
(PGE2) is mainly produced by osteoblasts during bone re-
sorption associated with inﬂammation and acts as a potent
stimulator of bone resorption [1]. Inﬂammatory cytokines,
such as interleukin (IL)-1 and tumor necrosis factor α
(TNFα) which induces PGE2 production by osteoblasts, and
PGE2 are able to induce the expression of receptor activator
of NF-κB ligand (RANKL) on the surface of osteoblasts.
Two types of cyclooxygenase (COX), COX-1 and COX-2,
are expressed in osteoblasts, and the expression of COX-2
is markedly induced by inﬂammatory stimulants. The block-
age of PGE2 synthesis by nonsteroidal anti-inﬂammatory
drugs (NSAIDs) could suppress RANKL-dependent osteo-
clastic bone resorption associated with inﬂammation [2, 3].
Membrane-bound PGE synthase-1 (mPGES-1) is also es-
sential for PGE2 synthesis in osteoblasts and PGE-mediat-
ed osteoclast diﬀerentiation [2, 3]. An mPGES-1-null mouse
demonstrated that PGE2 production by osteoblasts is essen-
tial for inﬂammatory bone loss induced by lipopolysaccha-
ride (LPS) in vivo [4].
The transient receptor potential (TRP) subfamily of ion
channels contains six members (TRPV1–TRPV6), most of
which were thermal-sensitive cation channels. TRPV1 has2 ISRN Pharmacology
been cloned from a cDNA library of the dorsal root ganglion
in sensory neurons, and the TRPV1 signal is suggested to be
a potential regulator of pain associated with thermal stim-
ulation [5, 6]. Capsaicin is a natural ligand for TRPV1 that
regulates nerve-related pain-sensitive signals, inﬂammation,
and cancer growth [7]. Mouse osteoblasts express TRPV1,
and capsaicin suppresses IL-1-induced osteoclast diﬀeren-
tiation in the cocultures of mouse bone marrow cells and
osteoblasts [8]. Rossi et al. [9] reported that human pre-
osteoclasts express TRPV1 and its signal modulates RANKL-
mediatedosteoclastdiﬀerentiation.Recentstudiessuggesting
some of the possible roles of TRPV1 in bone metabolism
are controversial, and the physiological and pharmacological
eﬀects of TRPV1 signals are not known in bone tissues. The
present study examined the eﬀects of capsaicin, a natural
TRPV1 ligand, on inﬂammatory bone resorption in vitro
and in vivo. These results showed that the TRPV1 sig-
nal suppressed osteoclastic bone resorption associated with
PGE2 production in vitro and attenuated inﬂammatory bone
loss induced by LPS in vivo.
2.MaterialsandMethods
2.1. Materials and Animals. Capsaicin (Figure 1(a))w a so b -
tained from Wako Pure Chemical Co. Ltd. (Tokyo, Japan).
LPS (Escherichia coli O55:B5) was purchased from Becton
Dickinson Co. Ltd. (Franklin lakes, NJ). PGE2 was obtained
from Sigma-Aldrich Co. LLC (St Louis, MO). Newborn (2-
day-old and 5-day-old) and adult (6-week-old) ddy mice
were obtained from Japan SLC Inc. (Shizuoka, Japan). A
PGE2 enzyme immunoassay (EIA) kit was purchased from
Amersham Co. Ltd. (Aylesbury, UK). All other chemicals
were of analytical grade.
2.2. Primary Mouse Osteoblastic Cells. Primary osteoblastic
cells were isolated from newborn mouse calvariae after ﬁve
routine sequential digestions with 0.1% collagenase (Wako
Pure Chemical) and 0.2% dispase (Godo Shusei Co. Ltd,
Tomakomai, Japan) as previously described [3]. Osteoblastic
cells collected from fractions 2–4 were combined and cultur-
ed in α-modiﬁed MEM (αMEM) supplemented with 10%
fetal calf serum (FCS) at 37◦C under 5% CO2 in air.
2.3. Osteoclast Formation. M o u s eb o n em a r r o wc e l l sw e r e
cocultured with the primary osteoblastic cells for 7 days. The
cells adhering to the well surface were stained for tartrate-
resistantacidphosphatase(TRAP),andTRAP-positivemult-
inucleated cells containing three or more nuclei per cell
were counted as osteoclasts as previously described [10].
The concentrations of PGE2 in the cultured medium were
determined using an enzyme immunoassay, as previously
described [10].
2.4. Bone-Resorbing Activity in Organ Culture of Mouse
Calvariae. Mouse calvariae were collected from 5-day-old
m i c ea n dt h e nw e r ec u l t u r e df o r2 4hi nB G J bm e d i u mc o n -
taining 1mg/mL bovine serum albumin (BSA). The calvaria
was transferred into new medium, with or without LPS after
24h, and then was cultured for 5 days at 37◦Cu n d e r5 %
CO2 in air. The bone-resorbing activity was determined by
measuring the concentration of calcium in the conditioned
medium using a calcium kit (calcium C test; Wako Pure
Chemical) as reported previously [2]. The bone-resorbing
activity was expressed as an increase in medium calcium,
which is consistent with the osteoclastic bone resorption as
shown in the previous studies [2].
2.5. RT-PCR Analysis. Primary mouse osteoblastic cells were
cultured for 24h in αMEM containing 1% FCS then treated
with LPS for 3h. The total RNA was extracted from mouse
osteoblasts using the acid guanidium-phenol-chloroform
method. cDNA was synthesized from 10μgo ft o t a lR N A
by reverse transcriptase (Superscript II Preampliﬁcation Sys-
tem; Invitrogen Life Technologies Co., Carlsbad, CA) and
ampliﬁed using PCR. Primers for the mouse COX-1, COX-2,
mPGES-1, and glyceraldehydes-3-phosphate dehydrogenase
(GAPDH) genes were used in PCR as reported previously
[4]. The PCR product was separated on a 1% agarose gel and
stained with ethidium bromide. The signals were quantiﬁed
using an image analyzer.
2.6.InﬂammatoryBoneLossinMice. Six-week-oldmicewere
i.p. injected with LPS (10mg/kg body weight) on days 0 and
4.TheLPSwasdissolvedinPBSforinjection.Themiceinthe
control group were injected with PBS. Some mice were i.p.
injected with capsaicin (1mg/kg body weight). The femurs
were collected 8 days after the ﬁrst injection of LPS or phos-
phate-buﬀered saline (PBS). For each group, 6–9 mice were
used. The bone mineral density (BMD) of femurs was meas-
ured by dual X-ray absorptiometry (model DCS-600R;
Aloka, Co. Ltd, Tokyo, Japan) as reported previously [4]. The
bone mineral content of the femurs was closely correlated
with the ash weight [4]. The BMD was calculated by dividing
the bone mineral content of the measured area by the area.
2.7.StatisticalAnalysis. Thedataareexpressedasthemean ±
SEM. The signiﬁcant diﬀerences were analyzed using Stu-
dent’s t-test.
3. Results
LPS markedly induced osteoclast diﬀerentiation in cocul-
tures of mouse bone marrow cells and osteoblasts on day 7,
while 30μM of capsaicin completely suppressed the osteo-
clast formation induced by LPS (Figure 1(b)). The condi-
tioned coculture medium was examined to ELISA to deter-
mine the eﬀects of capsaicin on PGE2production induced
by LPS. The level of PGE2 in the conditioned medium
treated with LPS was higher than that of the control and
was clearly suppressed by adding 30μM capsaicin in the
coculture (Figure 1(c)). Bone-resorbing activity was meas-
ured by the increase in calcium in the conditioned medium.
LPS markedly induced bone-resorbing activity in calvarial
cultures. The addition of 30μM capsaicin signiﬁcantly
suppressed the bone-resorbing activity induced by LPS
(Figure 1(d)). These results indicate that capsaicin clearlyISRN Pharmacology 3
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Figure 1: The eﬀects of capsaicin on LPS-induced osteoclast formation and PGE2 production in cocultures of osteoblasts and bone marrow
cells and on the bone-resorbing activity induced by LPS in mouse calvarial organ cultures. (a) Chemical structure of capsaicin. (b) Mouse
bone marrow cells and osteoblastic cells were cocultured for 7 days with 30μM capsaicin in the presence of LPS (1ng/mL). The cells were
stained for tartrate-resistant acid phosphatase (TRAP), a speciﬁc marker for osteoclasts, and the number of TRAP-positive multinucleated
cells containing 3 or more nuclei was counted. The data are expressed as the mean ± SEM of 4 independent wells. (c) The level of PGE2 was
measured by EIA using the conditioned medium of the cocultures. (d) Mouse calvariae were dissected in half and cultured with or without
capsaicin (30μM) in the presence of LPS (1μg/mL) for 5 days. The concentration of calcium in the medium was measured to calculate
bone-resorbing activity. Data are expressed as the mean ± SEM of 4 independent wells. A signiﬁcant diﬀerence between the two groups is
indicated, ∗P<0.001 versus control; #P<0.01 versus LPS; ##P<0.001 versus LPS.
suppressed the osteoclastic bone resorption associated with
inﬂammation in vitro.
PGE2 is mainly produced by osteoblasts in bone tissues.
The expression of COX-2 and mPGES-1 is essential for
PGE2 production by osteoblasts treated with bone-resorbing
cytokines such as IL-1 and LPS, and the PGE2 production
is essential for inﬂammatory bone resorption [4]. An RT-
PCRanalysisshowedtheexpressionofCOX-2andmPGES-14 ISRN Pharmacology
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Figure 2: Eﬀects of capsaicin on the production of PGE2 and the expression of COXs and mPGES-1 mRNAs in mouse primary osteoblasts.
(a) Mouse osteoblasts were cultured with LPS (1ng/mL) for 3h with or without capsaicin (30μM). Total RNA was extracted, and the
expression of COX-1, COX-2, and mPGES-1 mRNAs was detected using RT-PCR. The relative intensity of mRNA expression was calculated
and noted in the upper of respective signal. (b) Osteoblasts were treated with 30μM capsaicin in the presence of LPS (1ng/mL) for 24h. The
levels of PGE2 were measured using the conditioned medium. Data are expressed as the mean ± SEM of 3 independent wells. A signiﬁcant
diﬀerence between the two groups is indicated, ∗P<0.001 versus control; ##P<0.001 versus LPS.
mRNAs to be markedly induced by LPS in mouse primary
osteoblasts at 3h, and simultaneous addition of capsaicin
clearly suppressed both the COX-2 and mPGES-1 expression
(Figure 2(a)). A low level COX-1 mRNA expression was
detected in the osteoblasts, and this expression was not in-
ﬂuenced by LPS or capsaicin. Capsaicin signiﬁcantly sup-
pressed LPS-induced PGE2 production in mouse primary
osteoblast culture (Figure 2(b)).
LPS administration induces the severe loss of trabecular
bone in distal femurs in mice, and mPGES-1 knockout mice
are resistant to the bone loss induced by LPS [4]. The mice
werei.p.injectedwithcapsaicinwithorwithoutLPS,andthe
femurs were collected on day 8 for measurement of femoral
BMDs. Distal femoral BMD was markedly suppressed by
the treatment with LPS, and simultaneous treatment with
capsaicin signiﬁcantly restored the LPS-induced bone loss
in mice (Figure 3). Capsaicin did not inﬂuence the femoral
BMDs in the control mice without LPS.
4. Discussion
The present study showed that capsaicin, a TRPV1 ligand,
suppresses LPS-induced osteoclastic bone resorption associ-
ated with inﬂammation by inhibiting PGE2 production by
osteoblasts. PGE2 is a typical inducer of bone resorption
associated with inﬂammation. We have reported that PGE2
binds to the EP4 receptor, one of the PGE receptor subtypes
EP1-EP4, and induces the RANKL expression to stimulate
bone resorption, using agonist and antagonist of EPs and
respective EP-knockout mice [2, 11]. PGE2 produced by
osteoblasts binds to EP4 in osteoblasts and induces RANKL
expression via EP4-mediated signals. LPS markedly induces
the expression of COX-2 and mPGES-1 mRNAs in osteo-
blasts, and the PGE2 production is essential for RANKL-
dependent osteoclast formation [4]. The transcriptional reg-
ulationisimportanttounderstandthebiologicalsigniﬁcance
in target tissues because mPGES-1 is an inducible terminal
enzyme associated with PGE2 biosynthesis. The mRNA ex-
pression of mPGES-1 is coupled with COX-2, and the induc-
tion of COX-2 mRNA proceeded mPGES-1 after adding
LPS. The mouse COX-2 gene promoter possesses functional
regulatory elements for NF-κB, NFIL-6, AP-1, and c/EBPα
[12]. In contrast, the mouse mPGES-1 gene promoter pos-
sesses AP-1 and c/EBP, but not NF-κB[ 13]. Capsaicin
clearlysuppressedtheLPS-inducedexpressionofCOX-2and
mPGES-1mRNAsinosteoblastsinthepresentstudy.Further
studies are needed to deﬁne the transcriptional regulation of
COX-2 and mPGES-1 by capsaicin in osteoblasts.
Capsaicin, a typical ligand for TRPV1, is derived from
chili peppers, which elicit a burning sensation through
TRPV1 [5, 6]. Mouse primary osteoblasts and osteoblast cell
line MC3T3-E1 express TRPV1, but expression of TRPV1
mRNA is not detected in bone marrow macrophages, and
thatcapsaicinsuppressesIL-1-induced osteoclastdiﬀerentia-
tioninthecoculturesofmousebonemarrowcellsandosteo-
blasts [8]. In addition, both resiniferatoxin, a natural TRPV1
agonist, and olvanil, a synthetic TRPV1 agonist, suppress
osteoclast formation induced by IL-1 in the cocultures
(Miyaura and Inada; unpublished data). The present studyISRN Pharmacology 5
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Figure 3:Eﬀectsofcapsaicinonfemoralbonemassinmiceinjected
with LPS. The mice were injected with (+) LPS (10mg/kg of body
weight) or PBS (−) i.p. on days 0 and 4 with or without capsaicin
(1mg/kg of body weight). The femurs were collected on day 8 after
the ﬁrst injection to measure the bone mineral density (BMD).
BMD of distal femurs was measured by dual X-ray absorptiometry
(model DCS-600R; Aloka). Data are expressed as the mean ± SEM
of 6–9 mice. A signiﬁcant diﬀerence between the two groups is
indicated, ∗P<0.001 versus control; ##P<0.001 versus LPS.
found that capsaicin suppressed the PGE2 production in-
duced by LPS in osteoblasts and suppressed LPS-induced
osteoclast formation (Figures 1 and 2). These results indicate
that osteoblasts are main target cells for TRPV1 ligand in
bonetissuesandregulateosteoclastdiﬀerentiationassociated
with inﬂammation.
Chen et al. [14] reported that capsaicin acts on the ma-
crophagecelllineRAW264.7toattenuateLPS-inducedCOX-
2 expression, but RAW 264.7 cells do not express TRPV1.
On the other hand, Rossi et al. [9] have shown that human
mature osteoclasts express TRPV1 isoforms and TRPV1
agonistenhancestheexpressionandtheactivityofTRAPand
Cathepsin K, two speciﬁc osteoclast biomarkers. The addi-
tion of capsaicin to bone marrow macrophages cultures in
the presence of soluble RANKL and macrophage colony
stimulatingfactor(M-CSF)doesnotinﬂuenceosteoclastdif-
ferentiation from macrophages (Miyaura and Inada; unpub-
lished data). Idris et al. [15] have shown that capsazepine, a
TRPV1 antagonist, acts on preosteoclasts and suppresses the
diﬀerentiation into mature osteoclasts. Therefore, the roles
of TRPV1 signals still remain controversial in macrophages,
preosteoclasts, and mature osteoclasts.
The current study showed that capsaicin signiﬁcantly
restored inﬂammatory bone loss in the femur induced by
LPS in mice (Figure 3). Therefore, TRPV1 ligands possess
potential as clinical drugs targeting bone diseases associated
with inﬂammatory bone resorption. Sancho et al. [16]
reported that capsaicin has the potential to protect against
inﬂammatory bowel diseases associated with severe inﬂam-
mation, thus indicating the anti-inﬂammatory eﬀects of
TRPV1 signal in intestinal diseases. Idris et al. [15]r e p o r t e d
that the TRPV1 antagonist capsazepine inhibits bone loss
due to estrogen deﬁciency in ovariectomized (OVX) mice.
However,themechanismsofbonelossinOVXanimalsdiﬀer
from that in LPS-treated animals accompanied with severe
inﬂammation. In addition, Clark et al. [17] reported that
TRPV4, a calcium permeable ion channel, possess chon-
droprotective role and deletion of TRPV4 gene resulted in
severe osteoarthritis using TRPV4 knockout mice. Further
studies using several animal models for bone and cartilage
diseases are needed to deﬁne the possible roles of TRPVs sig-
nals in bone.
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